Pancytopenia is common in HIV-infected patients. Abnormal hematologic findings are attributable to direct and indirect effects of HIV itself, opportunistic infections, and toxicity of therapeutic agents. Malignancies, malnutrition, and autoimmunity are other contributors to a usually multifactorial etiology [1] . Hemophagocytic lymphohistiocytosis (HLH) is an uncommon cause of pancytopenia and has an extremely poor outcome if not identified and treated promptly. Described primarily in children in association with viral infections, HLH has also been associated with bacterial, fungal, and parasitic infections and with noninfectious disorders, such as malignancy and autoimmune diseases. Immune dysregulation is thought to be a key factor in its pathogenesis [2] , and HIV-infected patients, because of their propensity for acquiring opportunistic infec-tions, are at increased risk for this reactive phenomenon [3, 4] . We describe a patient with AIDS who developed candidiasisassociated HLH. We also review the previously reported 38 cases of this unusual clinical syndrome in HIV-infected patients and try to specify clinical and biological characteristics of HLH in such patients (table 1) .
Case report. A 38-year-old woman was found unresponsive at home and admitted to the hospital following resuscitation after cardiopulmonary arrest. Four days before admission, the patient had developed fever, productive cough, fatigue, and generalized malaise. Past medical history was significant for HIV infection, oral candidiasis, mild anemia, and recent tubo-ovarian abscess. The CD4 cell count 1 month before admission was 65 cells/mm 3 (360-1725 cells/mm 3 ). Medications included zidovudine, lamivudine, nelfinavir, erythropoietin, and ferrous sulfate. The findings of a physical examination were remarkable for fever, skin pallor, petechiae, oropharyngeal candidiasis, and a palpable spleen tip. There was no lymphadenopathy, hepatomegaly, or skin rash. Results of laboratory tests revealed a hemoglobin level of 5.3 g/dL (normal range, 12-16 g/dL), a hematocrit of 16% (normal range, 37%-48%), a WBC count of 1400 cells/mm 3 (normal range, 4000-10,500 cells/mm 3 ), and a platelet count of 24,000 platelets/mm 3 (normal range, 130,000-400,000 platelets/ mm 3 ). All of these values were significantly lower than those obtained 1 month earlier. The reticulocyte count of 0.6% suggested a hypoproliferative marrow.
The other striking findings included a markedly increased serum ferritin level of 12000 ng/mL (normal range, 10-200 ng/ mL), a serum lactate dehydrogenase level of 2596 U/L (normal range, 100-190 U/L), a serum triglyceride level of 689 mg/dL (normal value, !160 mg/dL), a prothrombin time of 16.9 s (normal value, !11.5 s), a serum creatinine level of 8.6 mg/dL (normal value, !1.2mg/dL), and a plasma lactate level of 12 mmol/L (normal range, 0.6-1.7 mmol/L). Test results were negative for antibodies against neutrophils, platelets, and parvovirus B-19. Sputum and blood cultures grew Candida albicans.
Amphotericin B therapy was promptly initiated, along with broad-spectrum antibiotics. A bone marrow biopsy revealed a hypocellular marrow, with trilineage hematopoiesis, an increased number of histiocytes (without atypia), and marked hemophagocytosis (figure 1). Methenamine silver staining of the bone marrow specimen revealed numerous pseudohyphae, and cultures of marrow grew C. albicans but remained negative for viruses and mycobacteria. Despite treatment with methylprednisolone (1 mg/kg q6h), intravenous immunoglobulins (0.5 g/kg/day for 2 days), and aggressive supportive care, the Micrograph of a bone marrow biopsy specimen obtained from our patient, revealing marked erythrophagocytosis by histiocytes. (Hematoxylin-eosin stain; original magnification, ϫ100.) patient died of overwhelming infection and multiorgan failure on the third day after admission. An autopsy revealed widespread dissemination of C. albicans and significant hemophagocytosis in the bone marrow, liver, and spleen.
Discussion. HLH, first described in 1939 [21] , is also referred to as hemophagocytic syndrome, histiocytic medullary reticulocytosis, and macrophage activation syndrome. According to the Histiocyte Society, the diagnosis of HLH requires fulfillment of the following 5 criteria: (1) fever, (2) cytopenia (2 of 3 lineages), (3) splenomegaly, (4) hypertriglyceridemia and/or hypofibrinogemia, and (5) hemophagocytosis [22] . In some cases, however, the disease may not adhere strictly to the proposed guidelines, and atypical presentations are to be expected. This is especially true of HIV-infected patients who may have some of the above nonspecific criteria in the absence of HLH or who may develop some of these criteria later in the course of the disease.
The majority (82%) of 39 cases reviewed in this report were males, and the mean age was 38 years (range, 26-59 years) (table 1). Fever was noted in 90% of all patients at the time of presentation. Among patients for whom respective blood counts were available, 100% were anemic, 78% were leukopenic, and 80% were thrombocytopenic. The mean hemoglobin concentration, mean WBC count, and mean platelet count were Downloaded from https://academic.oup.com/cid/article-abstract/37/11/e161/374165 by guest on 05 March 2019 7.5 g/dL, 2900 cells/mm 3 , and 78,000 platelets/mm 3 , respectively. The mean serum ferritin level was a striking 280 times the upper limit of the normal range (10-200 ng/mL) among the 15 patients for whom it was reported. Indeed, marked hyperferritinemia is common in patients with HLH and serves as a useful marker of disease activity and response to treatment [7, 23] . Hyperferritinemia probably results from damage to hepatocytes, although increased translation of ferritin mRNA induced by IL-1b has also been proposed [24] . Triglyceride levels were elevated in 9 of 11 patients. Hypertriglyceridemia is a useful marker of disease activity in other forms of HLH but is less reliable in HIV-infected patients, because of the nonspecific elevation in triglyceride levels in such patients, even in the absence of HLH [25] . The liver and spleen were enlarged in 67% and 55% of patients, respectively.
Hemophagocytosis, the hallmark of HLH, involves the pathological finding of activated histiocytes engulfing erythrocytes, leukocytes, platelets, and their precursor cells [26] . Histiocytes lack the nuclear atypia associated with the cells of malignant histiocytoses. The organs most frequently involved are the spleen, liver, lymph nodes, bone marrow, and, occasionally, CNS and skin. Varying degrees of hemophagocytosis are often found in the bone marrow of HIV-infected individuals without an underlying diagnosis of HLH, a finding that raises the possibility of subclinical forms of HLH [27] .
HLH is known to occur in association with a variety of infectious and noninfectious disorders. The variety of opportunistic infections and malignancies in HIV-infected patients increases the risk for HLH in such patients, and the risk increases with the severity of immunosuppression. The CD4 cell count was reported for 30 patients, and 80% had a count of !200 cells/mm 3 . The mean CD4 cell count was 132 cells/mm 3 . Commonly observed associations included disseminated histoplasmosis, Kaposi sarcoma, lymphoma, toxoplasmosis, mycobacterial (tuberculous as well as atypical) infection, and cytomegalovirus infection. Disseminated candidiasis alone in HIV-infected individuals with HLH has not been reported before, and the other previously reported cases had either oropharyngeal candidiasis or other coexisting conditions that might have potentially caused HLH [3, 5] . The absence of opportunistic infections or malignancies in as many as 11 patients and the resolution of HLH with antiretroviral therapy in 1 patient [8] points to a possible role of HIV itself in the pathogenesis of HLH.
The great variety of diseases associated with HLH suggests that it may be a reactive phenomenon. In fact, the macrophages in cases of HLH have been shown to exhibit an activated phenotype with increased functional activity and expression of major histocompatibility complex class I and II molecules and macrophage colony-stimulation factor receptors [28, 29] . It has been proposed that cytokine dysfunction in HLH causes the uncontrolled growth and nonmalignant accumulation and multivisceral infiltration of activated T lymphocytes and normal histiocytes, resulting in symptoms and signs of the disease. Key cytokines found at extremely elevated levels in the plasma of patients with HLH include IFN-g, TNF-a, IL-10, IL-12, and IL-2 receptor [30] . Immune dysregulation is thought to be responsible for such elevated cytokine levels. Profoundly decreased cytotoxic T lymphocyte function and absence of natural killer (NK) cell function are characteristic immunologic features of HLH and may serve to support its diagnosis [31] . Various genetic abnormalities have been linked to a familial form of HLH. Mutation of the perforin gene localized at 10q21-22 is especially interesting because of the central role of this gene in NK cell activity [32] . The hypercytokinemia and the generalized defects in T cell and NK cell cytotoxicity seen in HIV-infected patients may well explain their predisposition to severe HLH.
Supportive care and treatment of the underlying infection usually results in recovery for 60%-70% of patients with reactive HLH [33] . This is in striking contrast to the recovery rate of 28% observed among HIV-infected patients. Nearly 50% of all deaths occurred within 1 month after diagnosis of HLH, which further highlights the fulminant nature of this disease in HIV-infected patients. A trend toward a less favorable outcomes as the degree of immunosuppression increases is clearly evident. As many as 4 of 6 patients with a CD4 cell count of 1200 cells/mm 3 survived HLH, compared with only 5 of 24 patients with a CD4 cell count of !200 cells/mm 3 . Splenectomy, steroid therapy, intravenous immunoglobulin therapy, plasmapheresis, and immunochemotherapy with cyclosporine and etoposide are other therapeutic approaches and have variable results. In addition, use of HAART and subsequent immune reconstitution has led to recovery in some cases.
In conclusion, pancytopenia in patients with advanced HIV infection can create a diagnostic dilemma with multiple potential etiologies. However, in patients with concurrent candidiasis and/or evidence of other disseminated infections, the possibility of associated HLH should be considered. The large number of associated disorders contributes to the variability in clinical presentations and warrants a high level of suspicion for diagnosis of this rapidly fatal disorder. Aggressive diagnostic and therapeutic interventions made early in the course of disease may improve the eventual outcome.
